Bank of New York Mellon Corp - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 245 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$117,563,000
+46.9%
680,307
-2.3%
0.03%
+47.6%
Q4 2014$80,028,000
-46.7%
696,265
-27.5%
0.02%
-48.8%
Q3 2014$150,069,000
-68.8%
960,514
-75.4%
0.04%
-36.9%
Q2 2014$481,160,000
+101.9%
3,900,780
+69.6%
0.06%0.0%
Q1 2014$238,311,000
-18.0%
2,300,077
-28.8%
0.06%
-19.8%
Q4 2013$290,489,000
-39.2%
3,229,802
-54.8%
0.08%
+12.5%
Q3 2013$477,450,000
+114.0%
7,138,912
+111.7%
0.07%
+2.9%
Q2 2013$223,057,0003,371,9680.07%
Other shareholders

There were no reported owners of SALIX PHARMACEUTICALS INC in Q4 2013.

NameSharesValueWeighting ↓
View complete list of SALIX PHARMACEUTICALS INC shareholders